华禧联合科技，一家专业从事创新药物研究及药品生产技术开发、规程制订、技术转移与药政注册的研发企业，短短7年时间，凭借技术力量和商业信誉迅速崛起，目前在中国建有创新实验室，并在全球多家城市设有合作机构。华禧联合科技致力于在中国构建研发主导型现代医药企业，持续推动中国医药技术市场创新，诚聘业内精英及商界加盟。Huaxipharm Co., Ltd is an emerging, research-based pharmaceutical company headquartered at Beijing, in the capital of China. The company, run by a professionally qualified and capable management, is focused on the discovery, development and marketing of medicine, active pharmaceutical ingredients, API and the related CRO services in China as well as globally.Huaxipharm has established a large pharmaceutical research centre, which houses laboratories for natural products, medicinal-synthetic chemistry, process and scale-up chemistry and pharmaceutical R&D (formulations based on conventional and novel drug delivery systems). With the equipped advanced instruments, samples can be analyzed and characterized for structure and purity quickly, as which provides good guarantee for Huaxipharm’s R&D Activities.     华禧联合科技集团是一家专业从事技术创新与合同服务的药物研发组织，集团于2003年初注册成立，注册资金1000万元人民币，目前拥有1500多平米的标准化实验室,并在美国费城、英国、印度和中国香港设有海外分公司及合作实验室，山东合资原料药、中间体及制剂生产企业建设中。集团属中关村科技园区高新技术企业，北京市新技术产业开发试验区高新技术企业协会会员。